Kathi Kinnett's Blog – April 2012 Archive (1)

AVI Summary Announcement

This morning, AVI BioPharma released information discussing their findings thus far in their Phase IIb study of Eteplirsen.



About Eteplirsen

Eteplirsen uses AVI’s phosphorodiamidate morpholino oligomer (PMO)-based chemistry to skip exon 51 of the dystrophin…

Continue

Added by Kathi Kinnett on April 2, 2012 at 4:00pm — 15 Comments

Monthly Archives

2018

2017

2016

2015

2014

2013

2012

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2019   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service